Drug Discovery Firm using Artificial Intelligence spins out of the Stanford research

Several companies are getting into artificial intelligence for discovering new drugs and this trend is continuously growing.

Among some of the latest entrants in Artificial Intelligence is Genesis Therapeutics, which was recently launched formally on the back of 4.1 million dollars in seed funding from very well-known investors of Silicon Valley like Andreessen Horowitz. It is based in South San Francisco, and was spun out of researc....